Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2010
Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia
Chengzhi Xie, Holly Edwards, Xuelian Xu, et al.
Biochemical Pharmacology
|
August 21, 2023
Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms
Jenna L Carter, Yongwei Su, Xinan Qiao, et al.
Molecular Cancer Therapeutics
|
June 24, 2010
Telomerase as an important target of androgen signaling blockade for prostate cancer treatment
Shuang Liu, Yanfeng Qi, Yubin Ge, et al.
Plos One
|
November 24, 2011
A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy
Ana C Xavier, Holly Edwards, Alan A Dombkowski, et al.
Oncotarget
|
June 3, 2017
Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer
Changwen Ning, Min Liang, Shuang Liu, et al.
Scientific Reports
|
February 9, 2017
Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells
Jun Ma, Xinyu Li, Yongwei Su, et al.
Signal Transduction and Targeted Therapy
|
April 17, 2020
Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia
Daniel A Luedtke, Yongwei Su, Jun Ma, et al.
Cancer Cell
|
November 14, 2018
A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis
Andrew Volk, Kaiwei Liang, Praveen Suraneni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2016
Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells
Xiaojia Niu, Jianyun Zhao, Jun Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2019
Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia
Jun Ma, Shoujing Zhao, Xinan Qiao, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2010
Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia
Chengzhi Xie, Holly Edwards, Xuelian Xu, et al.
Biochemical Pharmacology
|
August 21, 2023
Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms
Jenna L Carter, Yongwei Su, Xinan Qiao, et al.
Molecular Cancer Therapeutics
|
June 24, 2010
Telomerase as an important target of androgen signaling blockade for prostate cancer treatment
Shuang Liu, Yanfeng Qi, Yubin Ge, et al.
Plos One
|
November 24, 2011
A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy
Ana C Xavier, Holly Edwards, Alan A Dombkowski, et al.
Oncotarget
|
June 3, 2017
Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer
Changwen Ning, Min Liang, Shuang Liu, et al.
Scientific Reports
|
February 9, 2017
Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells
Jun Ma, Xinyu Li, Yongwei Su, et al.
Signal Transduction and Targeted Therapy
|
April 17, 2020
Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia
Daniel A Luedtke, Yongwei Su, Jun Ma, et al.
Cancer Cell
|
November 14, 2018
A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis
Andrew Volk, Kaiwei Liang, Praveen Suraneni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2016
Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells
Xiaojia Niu, Jianyun Zhao, Jun Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 20, 2019
Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia
Jun Ma, Shoujing Zhao, Xinan Qiao, et al.
Page
of 14